Conceptio › Archive › HAL (France)
HAL (France)open access

GABRINOX-2 protocol: a French, prospective, multicentre, randomised phase II trial evaluating gemcitabine/nab-paclitaxel followed by FOLFIRINOX versus FOLFIRINOX alone as first-line treatment for metastatic pancreatic cancer

Fabienne Portales et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
chemotherapyclinical-trialrisk-factors
Clinical Trial, Clinical Protocols, Risk Factors, 0, CHEMOTHERAPY, 1, Gastrointestinal tumours
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 1133876
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.